Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
123.5 USD | -0.97% | -0.70% | -11.24% |
Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.26% | 19.86B | |
+7.82% | 220B | |
+6.48% | 183B | |
+10.46% | 133B | |
+24.39% | 107B | |
-0.95% | 63.05B | |
+11.29% | 51.74B | |
+4.81% | 50.47B | |
-0.99% | 40.91B | |
+24.20% | 31.91B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail